 |
|
Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
April 30, 2008Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the growth inhibitory activity of doxorubicin or cisplatin, as single agents, may be modified in combination with emblic myrobalan or belleric myrobalan extracts and may be synergistically enhanced in some cases.
An article to be published on March 14, 2008, in the World Journal of Gastroenterology demonstrates the combination of effective phytochemicals with chemotherapeutic agents. A study was conducted by Khosit Pinmai of Thammasat University, in which he evaluated the interaction of myrobalan extracts with chemotherapeutic drugs on cancer cell growth by isobologram and the combination index (CI) method of Chou-Talalay.
Several studies have shown that doxorubicin and cisplatin have harmful effects on health and can lead to the development of primary and secondary drug resistance in tumor cells, thereby limiting the clinical success of cancer chemotherapy. Recent reports show that combination chemotherapy is a superior modality and that naturally occurring dietary supplements with known anti-cancer properties could be used in combination chemotherapy to reduce the systemic toxicity of chemotherapeutic agents.
The study provides corroborative evidence, as it shows that emblic myrobalan and belleric myrobalan extracts were selectively toxic against two cancer cell lines and that in combination with doxorubicin and cisplatin produced an increased growth inhibitory effect in both hepatocellular carcinoma (HEpG2) and lung cancer (A549) cells. When using synergistic drug combinations at corresponding dose levels, the calculation of the dose reduction index (DRI) at the IC50 demonstrated possible reductions in doxorubicin concentrations for the drug combinations, ranging from 1.64-fold (myrobalan + doxorubicin in A549) to 4.69-fold (myrobalan + doxorubicin in HEpG2). The dose reduction level was different and specific to each combination and cell line. These findings support the hypothesis that combinations of plant extracts and chemotherapeutic agents allow a reduction in the dosage of the latter (e.g., doxorubicin and cisplatin), while retaining the benefits but minimizing the cytotoxic effects, thus enhancing therapeutic efficacy.
In the view of the authors, the mechanism of interaction between myrobalan extracts and chemotherapeutic drugs is unclear, and it is possible that multiple compounds in the myrobalan extracts are involved. Previously, phytochemical studies have shown that myrobalan contains a variety of chemical components, including hydrolysable tannins (e.g., emblicanin, gallic acid and ellagic acid).
Further studies are needed to assess the underlying mechanism(s) and signal transduction pathways leading to growth inhibition induced by single agents and combinations both in vitro and in vivo.
World Journal of Gastroenterology
The study provides corroborative evidence, as it shows that emblic myrobalan and belleric myrobalan extracts were selectively toxic against two cancer cell lines and that in combination with doxorubicin and cisplatin produced an increased growth inhibitory effect in both hepatocellular carcinoma (HEpG2) and lung cancer (A549) cells. When using synergistic drug combinations at corresponding dose levels, the calculation of the dose reduction index (DRI) at the IC50 demonstrated possible reductions in doxorubicin concentrations for the drug combinations, ranging from 1.64-fold (myrobalan + doxorubicin in A549) to 4.69-fold (myrobalan + doxorubicin in HEpG2). The dose reduction level was different and specific to each combination and cell line. These findings support the hypothesis that combinations of plant extracts and chemotherapeutic agents allow a reduction in the dosage of the latter (e.g., doxorubicin and cisplatin), while retaining the benefits but minimizing the cytotoxic effects, thus enhancing therapeutic efficacy.
In the view of the authors, the mechanism of interaction between myrobalan extracts and chemotherapeutic drugs is unclear, and it is possible that multiple compounds in the myrobalan extracts are involved. Previously, phytochemical studies have shown that myrobalan contains a variety of chemical components, including hydrolysable tannins (e.g., emblicanin, gallic acid and ellagic acid).
Further studies are needed to assess the underlying mechanism(s) and signal transduction pathways leading to growth inhibition induced by single agents and combinations both in vitro and in vivo.
World Journal of Gastroenterology
More Myrobalan Current Events and Myrobalan News Articles
 |
Myrobalan Of The Magi by alan Jacobs (Author) |
 |
Himalaya Pure Herbs Triphala, Digestive Support, 60 Vcaps, 250 mg (Pack of 2) by Himalaya Herbal Healthcare Triphala + 60 Vcaps + Digestive Support + Triphala is a traditional combination of three myrobalan fruits: Amla, Belleric Myrobalan and Chebulic Myrobalan. It supports the normal function of the membrane lining for the whole digestive tract. (These statem |
|
Indian trade enquiry: Drugs and tanning materials : reports on cinchona bark and myrobalans by Imperial Institute (Author) | |
 |
Source Naturals Pine Slim 30 Sg, 2.4 Bottle by Source Naturals Triphala is a combination of three fruits (‘tri’ meaning three, ‘phala’ meaning fruits) that is described in the ancient Ayurvedic health text Charaka Samhita (circa 1500 BC) and throughout Ayurvedic literature as a tonifying, strengthening blood cleanser and gentle laxative. Each of the three fruits has specific health properties, confirmed by modern research. The fruit of behada and the rind of harada are known as gentle purgatives. The fruit of amla is a rich source of vitamin C, and the other fruits also contain tannins, lignans, and flavonoids that have antioxidant properties. For thousands of years, this formula has been used in India for healthy digestion and elimination. |
|
The Emblick Myrobalan. by Elizabeth BLACKWELL (Author) | |
 |
Trifal, 90c by Ayush Herbs Trifal is a combination of three herbs Terminalia chebula (haritaki), Terminalia bellerica (bahera), and Embelica officinalis (amla) which is referred in almost every Ayurvedic textbook and is considered adaptogenic. This combination has synergistic action, as well as digestive and mild diuretic properties. Haritaki is rich in tannins, amino acids, succinic acid and beta-sitosterol. Bahera is rich in tannins, and has antihistaminic, antifungal, yeast-inhibiting and choleretic effects. Amla supports the immune system and is one of the richest available sources of Vitamin C. TrifalTM has bowel-regulating and mild laxative effects, aiding both digestion and elimination. |
 |
Dabur (Triphala) Nature 4 U 60 Capsules by Dabur Made from powder of 3 Myrobalans (Triphala) |
|
Drugs and tanning materials: Reports on cinchona bark and myrobalans by Imperial Institute (Author) | |
|
Integrative Therepeutics Blue Heron 120 Ultracaps by Integrative Therapeutics This blend of amla fruit, belleric myrobalan fruit, and chebulic myrobalan fruit is a time-tested group of Ayurvedic herbal fruits that promote healthy digestion. |
| © 2009 BrightSurf.com |